MA32530B1 - Dérivés de spirocétals cristallins et procédé pour la préparation de dérivés de spirocétals - Google Patents

Dérivés de spirocétals cristallins et procédé pour la préparation de dérivés de spirocétals

Info

Publication number
MA32530B1
MA32530B1 MA33442A MA33442A MA32530B1 MA 32530 B1 MA32530 B1 MA 32530B1 MA 33442 A MA33442 A MA 33442A MA 33442 A MA33442 A MA 33442A MA 32530 B1 MA32530 B1 MA 32530B1
Authority
MA
Morocco
Prior art keywords
spirocital
derivatives
crystalline
preparation
methods
Prior art date
Application number
MA33442A
Other languages
Arabic (ar)
English (en)
Inventor
Masatoshi Murakata
Takuma Ikeda
Nobuaki Kimura
Akira Kawase
Masahiro Nagase
Keisuke Yamamoto
Noriyuki Takata
Shinichi Yoshizaki
Koji Takano
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41434188&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA32530(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of MA32530B1 publication Critical patent/MA32530B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/04—Carbocyclic radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00—Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12

Abstract

L'invention porte sur un procédé de fabrication d'un dérivé de spirocétal par l'intermédiaire d'un composé représenté par la formule (vi) [dans laquelle les groupes variables et les nombres variables sont tels que définis dans la description] qui peut être obtenu à partir d'un dérivé d'alcool dihalobenzylique par une réaction monotope.
MA33442A 2008-06-20 2010-12-20 Dérivés de spirocétals cristallins et procédé pour la préparation de dérivés de spirocétals MA32530B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008162073 2008-06-20
PCT/JP2009/061226 WO2009154276A1 (fr) 2008-06-20 2009-06-19 Cristaux de dérivé de spirocétal et leur procédé de fabrication

Publications (1)

Publication Number Publication Date
MA32530B1 true MA32530B1 (fr) 2011-08-01

Family

ID=41434188

Family Applications (1)

Application Number Title Priority Date Filing Date
MA33442A MA32530B1 (fr) 2008-06-20 2010-12-20 Dérivés de spirocétals cristallins et procédé pour la préparation de dérivés de spirocétals

Country Status (25)

Country Link
US (2) US8569520B2 (fr)
EP (3) EP4036100A1 (fr)
JP (2) JP4823385B2 (fr)
KR (1) KR101856784B1 (fr)
CN (1) CN102046645B (fr)
AR (1) AR072211A1 (fr)
AU (1) AU2009261129A1 (fr)
CA (1) CA2727923A1 (fr)
CL (1) CL2010001485A1 (fr)
CO (1) CO6351798A2 (fr)
CR (1) CR20110033A (fr)
EC (1) ECSP11010773A (fr)
ES (1) ES2907611T3 (fr)
HK (1) HK1154589A1 (fr)
IL (1) IL210098A0 (fr)
MA (1) MA32530B1 (fr)
MX (1) MX2010014023A (fr)
NZ (1) NZ589961A (fr)
PE (1) PE20110115A1 (fr)
PL (1) PL3170834T3 (fr)
RU (1) RU2011101972A (fr)
SG (1) SG193795A1 (fr)
TW (1) TW201011043A (fr)
WO (1) WO2009154276A1 (fr)
ZA (1) ZA201100016B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011074675A1 (fr) * 2009-12-18 2011-06-23 中外製薬株式会社 Procédé de préparation d'un dérivé spirocétal
WO2012115249A1 (fr) * 2011-02-25 2012-08-30 中外製薬株式会社 Cristal de dérivé de spirocétal
AU2012320581B2 (en) * 2011-10-06 2017-03-30 Bayer Intellectual Property Gmbh Heterocyclylpyri (mi) dinylpyrazole as fungicidals
KR102395687B1 (ko) 2013-12-27 2022-05-06 추가이 세이야쿠 가부시키가이샤 토포글리플로진을 함유하는 고형 제제 및 그 제조 방법
CN106188190B (zh) * 2016-07-28 2020-08-25 迪嘉药业集团有限公司 一种托格列净一水合物的制备方法
BR112019005930A2 (pt) 2016-10-19 2019-06-11 Boehringer Ingelheim Int combinações compreendendo um inibidor de ssao/vap-1 e um inibidor de sglt2, e usos das mesmas
CN108640958B (zh) * 2017-05-05 2021-03-30 镇江圣安医药有限公司 异苯并呋喃衍生物、其药物组合物和制剂以及用途
WO2019201752A1 (fr) 2018-04-17 2019-10-24 Boehringer Ingelheim International Gmbh Composition pharmaceutique, méthodes de traitement et utilisations associées

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL63968A (en) 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
HU196775B (en) * 1986-08-05 1989-01-30 Richter Gedeon Vegyeszet Process for production of morfologically unique new modifications of famotidin and medical compositions containing such substances
PT98344B (pt) 1991-07-17 1999-04-30 Lneti Lab Nac De Eng Tec Ind D Processo para a obtencao de espirocetais labdanicos do tipo ambar cinzento
GB9426103D0 (en) 1994-12-23 1995-02-22 Merck Sharp & Dohme Therapeutic agents
JP2000044534A (ja) * 1998-07-28 2000-02-15 Mitsui Chemicals Inc Ｎ保護基アミノ酸の製造法
DE60140348D1 (de) 2000-02-02 2009-12-17 Banyu Pharma Co Ltd Verfahren zur verwandlung einer funktionellen gruppe durch halogen-metal-austausch
JP3849024B2 (ja) 2003-03-26 2006-11-22 国立大学法人 東京大学 有機亜鉛錯体およびその製造方法
TW200637869A (en) 2005-01-28 2006-11-01 Chugai Pharmaceutical Co Ltd The spiroketal derivatives and the use as therapeutical agent for diabetes of the same
CN101389632B (zh) 2005-12-23 2013-02-06 生态生物有限公司 螺缩酮
US7803778B2 (en) 2006-05-23 2010-09-28 Theracos, Inc. Glucose transport inhibitors and methods of use
TWI403516B (zh) 2006-07-27 2013-08-01 Chugai Pharmaceutical Co Ltd To replace spirocyclic alcohol derivatives, and its use as a therapeutic agent for diabetes
JP5791983B2 (ja) 2011-07-07 2015-10-07 三井化学株式会社 樹脂組成物、これを用いたポリイミド金属積層体、及び電子回路用基板

Also Published As

Publication number Publication date
US20140024817A1 (en) 2014-01-23
EP3170834B1 (fr) 2022-02-09
JP4823385B2 (ja) 2011-11-24
EP2308886A4 (fr) 2013-04-03
ECSP11010773A (es) 2011-02-28
JPWO2009154276A1 (ja) 2011-12-01
CR20110033A (es) 2011-02-16
JP2012001554A (ja) 2012-01-05
RU2011101972A (ru) 2012-07-27
SG193795A1 (en) 2013-10-30
ES2907611T3 (es) 2022-04-25
EP3170834A1 (fr) 2017-05-24
NZ589961A (en) 2012-12-21
CN102046645B (zh) 2015-04-01
MX2010014023A (es) 2011-02-15
PL3170834T3 (pl) 2022-05-02
CA2727923A1 (fr) 2009-12-23
CN102046645A (zh) 2011-05-04
KR20110020909A (ko) 2011-03-03
IL210098A0 (en) 2011-02-28
US9163051B2 (en) 2015-10-20
AR072211A1 (es) 2010-08-11
EP4036100A1 (fr) 2022-08-03
PE20110115A1 (es) 2011-02-14
WO2009154276A1 (fr) 2009-12-23
KR101856784B1 (ko) 2018-05-10
HK1154589A1 (en) 2012-04-27
ZA201100016B (en) 2012-03-28
US8569520B2 (en) 2013-10-29
EP2308886B1 (fr) 2016-12-07
CO6351798A2 (es) 2011-12-20
TW201011043A (en) 2010-03-16
AU2009261129A1 (en) 2009-12-23
US20110306778A1 (en) 2011-12-15
EP3170834B8 (fr) 2022-03-23
EP2308886A1 (fr) 2011-04-13
CL2010001485A1 (es) 2011-09-16
JP5485237B2 (ja) 2014-05-07

Similar Documents

Publication Publication Date Title
MA32530B1 (fr) Dérivés de spirocétals cristallins et procédé pour la préparation de dérivés de spirocétals
EA200800886A1 (ru) Способ получения 1-н-имидазо[4,5-с]пиридинов и их аналогов
EA200900817A1 (ru) Способ получения фторметилзамещённых гетероциклических соединений
ATE451351T1 (de) Vitamin-d-analogon nel, verfahren und seine verwendung
HK1145684A1 (en) Process for preparing benzofurans
BRPI0815534A2 (pt) "método para produzir pelo menos um alcool c2-c4 a partir de gás de síntese, método para produzir etanol a partir de gás de sintese e aparelho capaz de reproduzir pelo menos um alcóol c2-c4 a partir de gás de síntese"
BRPI0606672A2 (pt) composto, processo de preparação, composição, composição de perfumaria e cosmética, produto de manutenção doméstica, uso
GT200500296A (es) Sintesis asimetrica de derivados del dehidrobenzofurano
DE602006009943D1 (de) Herstellung von glycerolderivaten und zwischenprodukte dafür
DK1877384T3 (da) Fremgangsmåde til fremstilling af eventuelt 2-substituerede 1,6-dihydro-6-oxo-4-pyrimidincarboxylsyrer
AR051373A1 (es) Procedimiento para la preparacion de analogos aciclicos de nucleotidos de fosfonatos
DK1832587T3 (da) Fremgangsmåde til fremstilling af moxifloxacin og moxifloxacin-hydrochlorid
MY148301A (en) Process for the preparation of optically pure or optically enriched enantiomers of sulphoxide compounds
MY171292A (en) Synthesis of polymer conjugates of indolocarbazole compounds
BRPI0516192A (pt) composto, e, método para a preparação de um composto
TNSN08261A1 (fr) Nouveaux composés polyinsaturés, leur procédé de préparation et les compositions les contenant
EA200900008A1 (ru) Новые хиральные промежуточные продукты, способ их получения и их применение в производстве толтеродина, фезотеродина или их активных метаболитов
MA33596B1 (fr) Procédé photochimique pour la production d'artémisinine
WO2006119125A3 (fr) Méthodes de synthèse de caroténoïdes comprenant des analogues, des dérivés et des intermédiaires synthétiques et biologiques
ECSP099045A (es) Sal xinafoato de un compuesto de 5-oxazol-2-il-quinolina sustituido
BRPI0514000A (pt) método para a produção de derivados de diarilcicloalquila
BRPI0514313A (pt) processo para sintetizar um composto, e, composto
ATE519745T1 (de) Verfahren zur herstellung von vorläufern für l-3, 4-dihydroxy-6-ä18füfluor-phenylalanin und 2- ä18füfluor-l-tyrosin und deren alpha-methylierten derivaten und die vorläufer
TN2012000166A1 (fr) NOUVEAUX DERIVES (HETEROCYCLE-TETRAHYDRO-PYRIDINE)-(PIPERAZINYL)-1-ALCANONE ET (HETEROCYCLE-DIHYDRO-PYRROLIDINE)-(PIPERAZINYL)-1-ALCANONE ET LEUR UTILISATION COMME INHIBITEURS DE p75
JP2013124248A (ja) ４，４−ジフルオロ−３，４−ジヒドロイソキノリン類の製造方法